These risks and uncertainties include competitive pressures in Cardinal Health's various lines of business; the amount or rate of generic deflation and our ability to offset generic deflation and maintain other financial and strategic benefits through our generic sourcing venture with CVS Health and other components of our generics pharmaceutical program; risks associated with the distribution of opioids, including potential financial impact associated with the outcome of the ongoing lawsuits and investigations by certain governmental and regulatory authorities and the risks associated with the ongoing global settlement framework discussions, including the risk that we may fail to reach a settlement agreement or that a final settlement could require us to pay more than we currently anticipate; risks associated with the recalls of our surgical gowns and affected Presource Packs, including the risk that the costs associated with the recalls, including inventory write-off costs and certain remediation and supply disruption costs, could have additional negative impact on our financial results, the possibility of government investigations or actions by regulators which could result in product seizures, suspension of our ability to produce, distribute or sell products and civil or criminal sanction, damage to our reputation, and loss of customers and sales; our ability to manage uncertainties associated with the pricing of branded pharmaceuticals; risks associated with our ability to improve the performance of our Medical segment's Cardinal Health Brand Products business; uncertainties due to government health care reform; and risks associated with our cost savings initiatives, including the possibility that they could result in greater charges or expenses than we anticipate, could fail to achieve the desired efficiencies or strategic outcomes and could have unintended consequences, such as business disruption. Non-GAAP distribution, selling, general and administrative expenses or Non-GAAP SG&A Except to the extent required by applicable law, Cardinal Health undertakes no obligation to update or revise any forward-looking statement. Our assumptions and estimates around this benefit and uncertain tax position require significant judgment since the definitive settlement terms and documentation, including provisions related to deductibility, under the Settlement Framework have not been negotiated and the U.S. tax law governing deductibility was changed by the U.S. Tax Cuts and Jobs Act ("Tax Act"). For more information on these measures, refer to the Use of Non-GAAP Measures and Definitions schedules. : distribution, selling, general and administrative expenses, excluding state opioid assessment related to prior fiscal years and surgical gown recall costs.  In February 2007, Cardinal Health signed a consent decree with the FDA which promised procedures to guarantee the safety of the Alaris SE. See insights on Cardinal Health including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. DUBLIN, Ohio, May 9, 2019 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported third quarter fiscal year 2019 revenues of $35.2 billion, an increase of 5 percent. Cardinal Health is backed by nearly 100 years of experience with operations in nearly 46 countries. Final terms of a settlement under the Settlement Framework continue to be negotiated, and there is no assurance that the necessary parties will agree to a definitive settlement agreement or that the contingencies to any agreement will be satisfied. Impairments and gain or loss on disposal of assets. The company makes annual product donations of over $9 million through international relief organizations and provides up to $1,000 in matching funds for every Cardinal Health employee that makes a charitable donation. In October 2019, we agreed in principle to a global settlement framework with a leadership group of state attorneys general that is designed to resolve all pending and future opioid lawsuits and claims by states and political subdivisions (the "Settlement Framework"). Cardinal Health is subject to additional risks and uncertainties described in Cardinal Health's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports. , In May 2020, Oklahoma Attorney General Mike Hunter sued Cardinal Health in Bryan County District Court, Oklahoma. , DEA investigation into Oxycodone diversion, Donna Leinwand Leger "DEA aims big in Cardinal Health painkiller case", Donna Leinwand Leger "Judge blocks Cardinal Health drug shipments in Fla.", United States Food and Drug Administration, "Cardinal Health moving some Dublin jobs to Philippines", "Turnaround succeeding, Cardinal Health says", "Walter steps down at Cardinal Health, P&G exec takes over", "Next Cardinal Health CEO sees bright future after spinoff", "Cardinal Health's CEO uses background to think outside the box", "Cardinal Health to name spinoff after CareFusion line", "Cardinal Health completes CareFusion spinoff", "CVS, Cardinal Health form U.S. generic drug venture", "Cardinal Health, CVS generics venture Red Oak on track for July start", "Cardinal Deal To Buy Pyxis In Stock Swap", "Cardinal Health to Purchase Owen Healthcare", Learning the business from the ground up: an interview with Steve Inacker, "Cardinal Health acquires VIASYS for $1.5B", "Cardinal Health Pays $517 Million for Obscure Specialty Pharma Firm", "Cardinal Health to acquire Cordis for $1.9 billion", "Cardinal Health to Buy J&J's Heart Business for $1.94B", "Cardinal Health Completes Acquisition Of Cordis", "Jones Day - Cardinal Health acquires Tradex International", "Cardinal Health to Acquire Leading Patient Product Portfolio from Medtronic for $6.1 Billion", "Cardinal Health Completes Acquisition of Medtronic's Patient Recovery Business", "Cardinal Health Revenue 2006-2018 | CAH", "Fortune 500 Companies 2018: Who Made the List", "CARDINAL HEALTH INC - 10-Q Quarterly Report", "Cardinal Health to Restate Net, Citing Bulk-Revenue Accounting", "Cardinal Health Suspends Production of Alaris SE Infusion Pump Following FDA Actions", "Cardinal Health Blocked From Shipping Painkiller in Florida", "Investigation: The DEA slowed enforcement while the opioid epidemic grew out of control", "Cardinal Health Announces Civil Settlement with DOJ", "Oklahoma Attorney General refiles opioid lawsuit against three distributors", "Benefactor of the Year: Cardinal Health Inc", "Cardinal Health Foundation invites healthcare providers to apply for grants to improve patient safety, efficiency", "Financial Statements for Cardinal Health, Inc. - Google Finance", "Hospital safety initiative helps Ohio kids", https://en.wikipedia.org/w/index.php?title=Cardinal_Health&oldid=979456660, Companies listed on the New York Stock Exchange, Health care companies established in 1971, Companies based in the Columbus, Ohio metropolitan area, Articles lacking reliable references from July 2020, Wikipedia articles with WorldCat identifiers, Creative Commons Attribution-ShareAlike License, Medical and pharmaceutical products and services, This page was last edited on 20 September 2020, at 21:55.